GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Other Current Receivables

Philogen SpA (STU:78Q) Other Current Receivables : €1.25 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Other Current Receivables?

Philogen SpA's Other Current Receivables for the quarter that ended in Jun. 2024 was €1.25 Mil.

Philogen SpA's quarterly Other Current Receivables increased from Jun. 2023 (€1.55 Mil) to Dec. 2023 (€1.91 Mil) but then stayed the same from Dec. 2023 (€1.91 Mil) to Jun. 2024 (€1.25 Mil).

Philogen SpA's annual Other Current Receivables increased from Dec. 2021 (€0.54 Mil) to Dec. 2022 (€2.93 Mil) but then declined from Dec. 2022 (€2.93 Mil) to Dec. 2023 (€1.91 Mil).


Philogen SpA Other Current Receivables Historical Data

The historical data trend for Philogen SpA's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Other Current Receivables Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Receivables
0.74 0.54 2.93 1.91

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 1.86 2.93 1.55 1.91 1.25

Philogen SpA Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Philogen SpA Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Industry
Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines